Financials ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 12/07/2024 BST 5-day change 1st Jan Change
336 USD +0.55% Intraday chart for ICON Public Limited Company +4.76% +18.71%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,239 10,290 25,209 15,860 23,304 27,784 - -
Enterprise Value (EV) 1 9,018 9,797 29,891 20,223 26,700 29,964 28,729 27,596
P/E ratio 25.4 x 31.7 x 138 x 31.7 x 38.3 x 33.6 x 27.4 x 23.8 x
Yield - - - - - - - -
Capitalization / Revenue 3.29 x 3.68 x 4.6 x 2.05 x 2.87 x 3.21 x 2.98 x 2.78 x
EV / Revenue 3.21 x 3.5 x 5.45 x 2.61 x 3.29 x 3.47 x 3.09 x 2.76 x
EV / EBITDA 18.2 x 20.6 x 30.8 x 13.7 x 15.8 x 16.2 x 14.2 x 12.5 x
EV / FCF 24.9 x 19 x 40.6 x 48 x 26.2 x 25.2 x 20 x 18 x
FCF Yield 4.01% 5.28% 2.46% 2.08% 3.82% 3.96% 5.01% 5.55%
Price to Book 5.71 x 5.56 x 3.13 x 1.87 x 2.53 x 2.75 x 2.48 x 2.27 x
Nbr of stocks (in thousands) 53,641 52,775 81,398 81,645 82,327 82,684 - -
Reference price 2 172.2 195.0 309.7 194.2 283.1 336.0 336.0 336.0
Announcement Date 19/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,806 2,797 5,481 7,741 8,120 8,644 9,309 9,999
EBITDA 1 495 475.7 970 1,479 1,694 1,848 2,028 2,216
EBIT 1 433.4 409.6 655 1,373 1,568 1,714 1,885 2,059
Operating Margin 15.45% 14.64% 11.95% 17.74% 19.31% 19.83% 20.25% 20.6%
Earnings before Tax (EBT) 1 427 381.2 196.7 567.9 624.5 953 1,130 1,311
Net income 1 374 332.3 153.2 505.3 612.3 807.4 973.6 1,126
Net margin 13.33% 11.88% 2.79% 6.53% 7.54% 9.34% 10.46% 11.27%
EPS 2 6.790 6.150 2.250 6.130 7.400 10.01 12.27 14.12
Free Cash Flow 1 361.9 516.9 735.4 421.2 1,020 1,187 1,439 1,532
FCF margin 12.9% 18.48% 13.42% 5.44% 12.57% 13.73% 15.46% 15.32%
FCF Conversion (EBITDA) 73.12% 108.66% 75.82% 28.47% 60.23% 64.21% 70.98% 69.12%
FCF Conversion (Net income) 96.77% 155.54% 480.07% 83.35% 166.63% 147.01% 147.83% 135.96%
Dividend per Share 2 - - - - - - - -
Announcement Date 19/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,885 1,902 1,935 1,942 1,962 1,979 2,020 2,055 2,066 2,090 2,142 2,189 2,224 2,253 2,299
EBITDA 1 332.5 340.6 354.3 379.6 405 399.1 414.2 432.5 448.2 444 453.2 468.3 481.7 488.9 495.9
EBIT 1 192.9 314 328.6 352.7 377.8 254 209.5 401.1 414.4 294.9 419.9 434.3 446.6 451.5 462.7
Operating Margin 10.23% 16.51% 16.98% 18.16% 19.25% 12.84% 10.37% 19.52% 20.06% 14.11% 19.61% 19.84% 20.08% 20.04% 20.13%
Earnings before Tax (EBT) 1 91.77 126 130.8 182.2 128.8 131.3 125.2 181.7 186.3 215.8 223 252.2 278.6 275.2 279.2
Net income 1 76.47 112 115.7 160.2 117.4 116.7 115.6 163.7 216.4 187.4 184.2 211.7 227.4 222 228.1
Net margin 4.06% 5.89% 5.98% 8.25% 5.99% 5.9% 5.72% 7.96% 10.47% 8.97% 8.6% 9.67% 10.23% 9.85% 9.92%
EPS 2 0.9200 1.360 1.410 1.940 1.420 1.410 1.400 1.970 2.600 2.250 2.382 2.662 2.840 2.853 2.950
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 22/02/22 27/04/22 27/07/22 02/11/22 22/02/23 26/04/23 26/07/23 25/10/23 21/02/24 24/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 4,682 4,364 3,396 2,180 945 -
Net Cash position 1 220 494 - - - - - 188
Leverage (Debt/EBITDA) - - 4.827 x 2.949 x 2.004 x 1.179 x 0.4658 x -
Free Cash Flow 1 362 517 735 421 1,020 1,187 1,439 1,532
ROE (net income / shareholders' equity) 25.2% 19.2% 13.4% 11.7% 6.9% 11.8% 12.5% 12.7%
ROA (Net income/ Total Assets) 14.2% 10.5% 6.4% 5.6% 3.58% 6.04% 6.71% 6.87%
Assets 1 2,631 3,171 2,394 9,017 17,088 13,365 14,501 16,405
Book Value Per Share 2 30.20 35.10 98.90 104.0 112.0 122.0 136.0 148.0
Cash Flow per Share 2 7.590 10.70 12.40 6.830 14.00 15.10 19.20 20.10
Capex 1 50.6 51.1 93.8 142 141 172 187 199
Capex / Sales 1.8% 1.83% 1.71% 1.84% 1.73% 1.99% 2.01% 1.99%
Announcement Date 19/02/20 24/02/21 22/02/22 22/02/23 21/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
336 USD
Average target price
364.2 USD
Spread / Average Target
+8.38%
Consensus
  1. Stock Market
  2. Equities
  3. ICLR Stock
  4. Financials ICON Public Limited Company